Alanous Therapeutics Patents – Insights & Stats (Updated 2023)

Alanous Therapeutics has a total of 192 patents globally, out of which 95 have been granted. Of these 192 patents, more than 05% patents are active. United States of America is where Alanous Therapeutics has filed the maximum number of patents, followed by Japan and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Alanous Therapeutics.

Alanous Therapeutics was founded in the year 2005. The Company operates as a clinical stage cellular immuno-oncology company. The Company focuses on the treatment of solid tumors through adoptive TCR-T cell therapy.

Do read about some of the most popular patents of Alanous Therapeutics which have been covered by us in this article and also you can find Alanous Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Alanous Therapeutics patent portfolio.

How many patents does the founder and the CEO of Alanous Therapeutics have?

The founder Jonathan Lewis has 1 patent and CEO Kevin Boyle has 0 patents.

How many patents does Alanous Therapeutics have?

Alanous Therapeutics has a total of 192 patents globally. These patents belong to 22 unique patent families. Out of 192 patents, 11 patents are active.

How Many Patents did Alanous Therapeutics File Every Year?

Alanous Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAlanous Therapeutics Applications FiledAlanous Therapeutics Patents Granted
20201
20191
20171
2016112
2015218
201458
2013106
201227
201184
201098

How many Alanous Therapeutics patents are Alive/Dead?

Alanous Therapeutics Patent Portfolio

How Many Patents did Alanous Therapeutics File in Different Countries?

Alanous Therapeutics Worldwide Patent Filing

Countries in which Alanous Therapeutics Filed Patents

CountryPatents
United States of America27
Japan9
Canada9
Europe9
Australia9
China8
New Zealand8
Taiwan7
Austria7
Singapore7
Israel7
Hong Kong (S.A.R.)6
Korea (South)5
Brazil5
Germany5
Denmark5
India5
Norway5
Spain4
South Africa4
Slovakia3
Russian Federation3
Portugal3
Mexico3
Poland3
Estonia2
Indonesia2
Hungary2
Slovenia2
Chile1
Cyprus1
Serbia1
Croatia1
Gulf Cooperation Council1

Where are Research Centres of Alanous Therapeutics Patents Located?

R&D Centers of Alanous Therapeutics

10 Best Alanous Therapeutics Patents

US6693119B2 is the most popular patent in the Alanous Therapeutics portfolio. It has received 36 citations so far from companies like Baxter International, Ironwood Pharmaceuticals and Bed Therapeutics.

Below is the list of 10 most cited patents of Alanous Therapeutics:

Publication NumberCitation Count
US6693119B236
US20060110462A124
US7452910B28
US20060280787A17
US20060040991A17
US9346836B25
US7579365B25
US20030023093A15
US6919344B24
US20080027110A13

What are Alanous Therapeutics key innovation segments?

What Technologies are Covered by Alanous Therapeutics?

The chart below distributes patents filed by Alanous Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Alanous Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Alanous Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Alanous Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.